Efficacy and safety of azithromycin and amoxicillin/clavulanate for otitis media in children: a systematic review and meta-analysis of randomized controlled trials

Autor: Solomon Mequanent, Eyasu Makonnen, Gabriel Dawit
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Male
Infectious and parasitic diseases
RC109-216
Cochrane Library
Azithromycin
Biomarkers
Pharmacological
law.invention
0302 clinical medicine
Randomized controlled trial
law
030212 general & internal medicine
030223 otorhinolaryngology
Child
Randomized Controlled Trials as Topic
General Medicine
QR1-502
Anti-Bacterial Agents
Infectious Diseases
Treatment Outcome
Meta-analysis
Child
Preschool
Drug Therapy
Combination
Female
medicine.symptom
Drug Monitoring
medicine.drug
Microbiology (medical)
medicine.medical_specialty
Adolescent
Subgroup analysis
RM1-950
Amoxicillin-Potassium Clavulanate Combination
Microbiology
Drug Administration Schedule
03 medical and health sciences
Amoxicillin/clavulanate
Internal medicine
medicine
Humans
Adverse effect
Otitis media
business.industry
Research
Infant
Amoxicillin
Otitis
Systematic review
Therapeutics. Pharmacology
business
Zdroj: Annals of Clinical Microbiology and Antimicrobials, Vol 20, Iss 1, Pp 1-9 (2021)
Annals of Clinical Microbiology and Antimicrobials
ISSN: 1476-0711
Popis: Background Resistance, prolonged therapy, and more adverse reactions made amoxicillin less preferred for treating otitis media. This study aimed to compare the efficacy and safety of azithromycin and amoxicillin/clavulanate for the treatment of otitis media in children. Methodology This study was a systematic review and meta-analysis. PubMed, Cochrane library, and Google scholar databases were searched. Comparative randomized clinical trial studies between azithromycin and amoxicillin/clavulanate to treat otitis media in children published up to 30 September 2019 were included. The risk of bias was assessed and Data was extracted by the first author and checked by the second author. Meta-analysis was performed by STATA software version 16, and Mantel–Haenszel statistical method with effect measure odds ratio was employed for analysis. Result 751 records were identified and 14 studies were eligible for analysis. In 12 studies azithromycin had equivalent clinical efficacy and 2 had less to amoxicillin/clavulanate. Meta-analysis results showed no statistically significant difference in efficacy in favor of amoxicillin/clavulanate after completion of treatment OR 0.75, 95% CI (0.62–0.91). On subgroup analysis for children less than 2 years (OR 0.96 95% CI (0.49–2.29), and greater than 2 years (OR 1.40 95% CI (0.93–2.11) and also efficacy on follow up (OR 0.97 95% CI (0.83–1.15) there is no statistically significant difference. The clinical adverse events are more in the amoxicillin/clavulanate group than in the azithromycin with a statistical significant difference OR 0.46 95% CI (0.43–0.56). Conclusion Azithromycin is comparable to amoxicillin/clavulanate to treat otitis media in children, and it is safer and more tolerable.
Databáze: OpenAIRE
Externí odkaz: